GlassScriptPhysician profile
Anthony A Castelli
NPI 1700260965
$25,751.96
in general payments reported to CMS, 2019-2025
7 companies · $4,363 in 2025
The $4,363 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $256 · 2021: $1,497 · 2022: $8,708 · 2023: $10K · 2024: $374 · 2025: $4,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $11K · Travel and Lodging: $2,622 · Food and Beverage: $2,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,500.00 |
| Travel and Lodging | $2,622.36 |
| Food and Beverage | $2,053.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $22,520.79 | 2020-2025 | Da Vinci Surgical System |
| Davol INC. | $2,534.82 | 2022-2025 | Phasix Mesh, Bard 3dmax Mesh |
| Kerecis Limited | $246.47 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $164.06 | 2024 | Restrata Wound Matrix |
| Medtronic, INC. | $156.56 | 2021 | |
| Baxter Healthcare | $116.70 | 2023 | Tisseel |
| Boston Scientific Corporation | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Castelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.